A new report analyses gaps in TB/HIV services in Ukraine

TB is both the most significant AIDS-related disease and the leading cause of death in PLHIV in Ukraine. The dual epidemics of TB and HIV continue to have significant impacts in the country, and pose multiple challenges for effective management and treatment of people living with HIV and TB.

Read More →

Open letter to Janssen: Reducing the price of bedaquiline

Several organizations and individuals working on TB appeal to Janssen to lower bedaquiline's price for all non-high-income countries.

Read More →

Attempt to shorten standard tuberculosis treatment fails in REMoxTB trial

Two 4-month treatment regimens containing moxifloxacin are less effective than the standard 6-month regimen for drug-sensitive tuberculosis.

Read More →

Global epidemic of diabetes threatens to jeopardise further progress in tuberculosis control

A Series of three papers in The Lancet Diabetes & Endocrinology examines the intersection between TB and diabetes from several angles, and outlines strategies that will be key to managing and ultimately reducing this dual disease burden.

Read More →

New tuberculosis blood test in children is reliable and highly specific

A newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.

Read More →

Union World Conference: Deadline extended for free civil society registrations

The deadline to apply for scholarships has been extended to 15 September 2014.

Read More →

Large trial will evaluate vaccine’s ability to prevent tuberculosis disease

Multi-site study underway in Africa

Read More →

WHO launches Companion Handbook on MDR-TB management

The Handbook has been developed for the purpose of describing ways to implement established WHO policies relevant for the management of MDR-TB.

Read More →

TAG symposium: Zero Accountability: when action doesn't match the numbers

2014 International Union Against TB and Lung Disease World Conference
Date: October 30, 2014
Time: 18h00 - 22h00
Location: Hotel Diagonal Zero Barcelona

Read More →

New TB drug bedaquiline: Weighing the benefits against the risks

Laia Ruiz Mingote and Dorothy Namutamba—co-chairs of CRAG— and Mike Watson Frick—TB/HIV Program Officer at Treatment Action Group—discuss the benefits and risks of using bedaquiline to treat TB.

Read More →

Page 1 of 43 · Total posts: 10

Older posts →

Login or register to be notified of new posts.

TAC logo TAG logo i-base logo EATG logo SADF logo CMT logo

TB Online is supported by the Treatment Action Campaign, Community Media Trust, South Africa Development Fund, Treatment Action Group, European AIDS Treatment Group and HIV i-Base.

The original material on this site is licensed under a Creative Commons Attribution 3.0 Unported License. Articles and images provided by 3rd-parties are subject to their licenses, though we strive to use free and open source materials wherever possible.
Creative Commons Licence badge